Guidelines for processing and reporting of prostatic needle biopsies

被引:79
作者
van der Kwast, TH
Lopes, C
Santonia, C
Pihl, CG
Neetens, I
Martikainen, P
Di Lollo, S
Bubendorf, L
Hoedemaeker, RF
机构
[1] Erasmus Med Ctr, Dept Pathol, Josephine Nefkens Inst, NL-3000 DR Rotterdam, Netherlands
[2] Inst Portugues Oncol Francisco Gentil, Dept Anat Pathol, P-4200 Oporto, Portugal
[3] Hosp Univ Getafe, Dept Anat Pathol, Madrid 28905, Spain
[4] Sahlgrens Univ Hosp, Dept Pathol, S-41685 Gothenburg, Sweden
[5] Acad hosp Middelheim, Dept Pathol, B-2020 Antwerp, Belgium
[6] Ctr Lab Med, Dept Pathol, FIN-33521 Tampere, Finland
[7] Univ Florence, Dept Pathol, I-50134 Florence, Italy
[8] Univ Basel, Inst Pathol, CH-4056 Basel, Switzerland
关键词
D O I
10.1136/jcp.56.5.336
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The reported detection rate of prostate cancer, lesions suspicious for cancer, and prostatic intraepithelial neoplasia (PIN) in needle biopsies is highly variable. In part, technical factors, including the quality of the biopsies, the tissue processing, and histopathological reporting, may account for these differences. It has been thought that standardisation of tissue processing might reduce the observed variations in detection rate. Consensus among the members of the pathology committee of the European Randomised study of Screening for Prostate Cancer (ERSPC) concerning the optimal methodology of tissue embedding resulting in guidelines for prostatic needle biopsy processing was reached. The adoption of an unequivocal and uniform way of reporting lesions encountered in prostatic needle biopsies is considered helpful for decision taking by the clinician. The definition of parameters for quality control of prostatic needle biopsy diagnostics will further facilitate clinical epidemiological multicentre studies of prostate cancer.
引用
收藏
页码:336 / 340
页数:5
相关论文
共 31 条
[1]  
Bostwick DG, 1996, CANCER, V78, P330, DOI 10.1002/(SICI)1097-0142(19960715)78:2<330::AID-CNCR22>3.0.CO
[2]  
2-W
[3]   ATYPICAL ADENOMATOUS HYPERPLASIA OF THE PROSTATE - MORPHOLOGIC CRITERIA FOR ITS DISTINCTION FROM WELL-DIFFERENTIATED CARCINOMA [J].
BOSTWICK, DG ;
SRIGLEY, J ;
GRIGNON, D ;
MAKSEM, J ;
HUMPHREY, P ;
VANDERKWAST, TH ;
BOSE, D ;
HARRISON, J ;
YOUNG, RH .
HUMAN PATHOLOGY, 1993, 24 (08) :819-832
[4]  
BOSTWICK DG, 1999, PROSTATE CANC
[5]  
Cohen RJ, 2000, PROSTATE, V43, P11, DOI 10.1002/(SICI)1097-0045(20000401)43:1<11::AID-PROS3>3.0.CO
[6]  
2-B
[7]   Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy? [J].
de la Taille, A ;
Rubin, MA ;
Bagiella, E ;
Olsson, CA ;
Buttyan, R ;
Burchardt, T ;
Knight, C ;
O'Toole, KM ;
Katz, AE .
JOURNAL OF UROLOGY, 1999, 162 (01) :103-106
[8]  
Epstein JI, 1996, CANCER, V78, P350, DOI 10.1002/(SICI)1097-0142(19960715)78:2<350::AID-CNCR26>3.0.CO
[9]  
2-U
[10]   Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy - A diagnosis that should not be made [J].
Epstein, JI .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (04) :477-478